Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 65
Filtrar
6.
Clin Exp Dermatol ; 39(7): 813-5, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25156341

RESUMO

Golimumab is a fully human anti-tumour necrosis factor (TNF)-α monoclonal antibody approved for use in the treatment of active rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Psoriasis induced by treatment with anti-TNF drugs is well documented, but to our knowledge, the development of clinical features of psoriasiform exfoliative erythroderma during treatment with golimumab has not been previously described.


Assuntos
Anticorpos Monoclonais/efeitos adversos , Dermatite Esfoliativa/induzido quimicamente , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...